DCF — TEXAS HEALTH ARLINGTON MEMORIAL HOSP
Enterprise Value: $-388.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-388.1M
Enterprise Value
$-125.2M
PV of Cash Flows
$-263.0M
PV of Terminal Value
$-423.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $313.7M | $-22.9M | -7.0% | $-36.2M | $-32.9M |
| Year 2 | $323.1M | $-20.3M | -6.0% | $-34.0M | $-28.1M |
| Year 3 | $332.8M | $-17.6M | -5.0% | $-31.7M | $-23.8M |
| Year 4 | $342.8M | $-16.4M | -5.0% | $-30.9M | $-21.1M |
| Year 5 | $353.1M | $-16.0M | -5.0% | $-31.0M | $-19.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-388.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$304.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07793083702103147
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5